This Viewpoint aims to provide an understanding of the current contrast in reimbursement for cancer treatment modalities in the US.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Beyond Tumor Size, Toward Meaningful Patient Outcomes | 0 | 8.26 | 08-10-2026 |
| 2 | Modernizing Surrogate Decision-Making to Reflect the Complexity of Cancer Care | 0 | 11.23 | 10-09-2026 |
| 3 | Rethinking Treatment Intensification in Poorly Chemosensitive Ovarian Cancer | 0 | 9.84 | 01-10-2026 |
| 4 | Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as Precancerous | 0 | 9.66 | 01-07-2026 |
| 5 | Cost Offset With Quadruple Therapy for Heart Failure | 0 | 9.43 | 01-08-2026 |
| 6 | Counting cancer: On making cancer a notifiable disease in India | 5 | 7 | 04-07-2026 |
| 7 | CAR T Cells and T-Cell Therapies for Cancer | 0 | 12.98 | 10-12-2024 |
| 8 | Trends in Prebiopsy MRI Utilization for Prostate Cancer Detection | 0 | 10.92 | 17-09-2026 |
| 9 | When Not to Push the Boulder | 0 | 5 | 02-07-2026 |